Gary Borzillo

Title: Gary Borzillo: Innovator in c-Met Antibody Treatments

Introduction

Gary Borzillo is a notable inventor based in Old Lyme, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of treatments using c-Met antibodies. With a total of 4 patents to his name, Borzillo's work has the potential to impact medical therapies significantly.

Latest Patents

Borzillo's latest patents focus on treatment methods using c-Met antibodies. These inventions relate to antibodies, including human antibodies and antigen-binding portions that specifically bind to c-Met, preferably human c-Met, and function to inhibit c-Met. The patents also cover human anti-c-Met antibodies and various forms of these antibodies, such as chimeric, bispecific, and single-chain antibodies. Additionally, the inventions include methods for making these antibodies, compositions comprising them, and their applications for diagnosis and treatment. Furthermore, the patents provide gene therapy methods using nucleic acid molecules encoding the immunoglobulin molecules that comprise the human anti-c-Met antibodies.

Career Highlights

Throughout his career, Gary Borzillo has worked with prominent companies in the biotechnology sector, including Amgen Fremont Inc. and Pfizer Corporation. His experience in these organizations has contributed to his expertise in developing innovative treatments.

Collaborations

Borzillo has collaborated with notable professionals in his field, including Neil R Michaud and Shama Kajiji. These collaborations have likely enhanced his research and development efforts.

Conclusion

Gary Borzillo is a distinguished inventor whose work on c-Met antibodies has the potential to revolutionize treatment methods in biotechnology. His contributions and collaborations reflect his commitment to advancing medical science.